Multimodal image characterization of paravenous atrophy

oc000116 10.3205/oc000116 urn:nbn:de:0183-oc0001160 Case Report Multimodal image characterization of paravenous atrophy Alba-Linero Alba-Linero Carmen C

Clinic Institute of Ophthalmology, Clinic Hospital of Barcelona, Sabino Arana 1, PC 08028, Barcelona, SpainClinic Institute of Ophthalmology, Clinic Hospital of Barcelona, Spain

carmen.alba.linero@gmail.com author Barberi Barberi Glenda Espinosa GE

Ophthalmology Department, Doctor Negrín University Hospital, Las Palmas de Gran Canaria, SpainOphthalmology Department, Doctor Negrín University Hospital, Las Palmas de Gran Canaria, Spain

author Llorens Llorens Victor V

Clinic Institute of Ophthalmology, Clinic Hospital of Barcelona, SpainClinic Institute of Ophthalmology, Clinic Hospital of Barcelona, Spain

author Socorro Alforja Castella Socorro Alforja Castella María M

Clinic Institute of Ophthalmology, Clinic Hospital of Barcelona, SpainClinic Institute of Ophthalmology, Clinic Hospital of Barcelona, Spain

author Adán Adán Alfredo A

Clinic Institute of Ophthalmology, Clinic Hospital of Barcelona, SpainClinic Institute of Ophthalmology, Clinic Hospital of Barcelona, Spain

author German Medical Science GMS Publishing House

Düsseldorf

610 paravenous atrophy multimodal image autofluorescence retinitis pigmentosa-like optical coherence tomography angiography 20190716 engl This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung). 2193-1496 9 GMS Ophthalmology Cases GMS Ophthalmol Cases 27 Objective: The objective is to describe a clinical case of paravenous atrophy using a multimodal image. Methods: A 48-year-old man was visited and followed in the ophthalmology department of Hospital Clinic (Barcelona). Visual acuity, slit-lamp exam, retinography, autofluorescence, visual field, optical coherence tomography, and electrophysiology test were performed. Results: The patient had a history of Behcet’s disease. Autofluorescence revealed hypoautofluorescence at the paravenous region, th visual field was also altered and electrophysiologic test were reduced.Conclusion: Paravenous atrophy is a rare entity not well described currently. Patients are frequently misdiagnosed. Multimodal image could help to characterize this condition properly and improve the management. IntroductionPigmented paravenous retinochoroidal atrophy (PPRCA), described as retino-choroiditis radiata in 1937 , is an uncommon disease with unknown etiology characterized b</PlainText></TextGroup>y bilateral retinal pigment epithelium (RPE) and choroidal atrophy along retinal veins, generally without macular involvement. The main physiopathologic theory supports that choroidal thinning precedes development of the RPE atrophy <TextLink reference="2"></TextLink>. PPRCA is commonly bilateral and symmetric, but appears to have variable expressivity and a spectrum of mild to severe ophthalmoscopic change <TextLink reference="3"></TextLink>. </Pgraph><Pgraph>Diagnosis is often fortuitously made during a routine exam and is based on a typical and characteristic fundus appearance. The principal differential diagnosis has to be done with typical retinitis pigmentosa (RP) <TextLink reference="4"></TextLink>.</Pgraph><Pgraph>Non-invasive imaging techniques including retinography, fundus autofluorescence (FAF), swept source optical coherence tomography (SS-OCT), and OCT angiography (Angio-OCT) are now available to the study of retinal dystrophies like this. We present a clinical case of PPRCA in association with Behcet's disease through multimodal study.</Pgraph></TextBlock> <TextBlock linked="yes" name="Case description"> <MainHeadline>Case description</MainHeadline><Pgraph>A 48-year-old man of Caucasian origin and ex-smoker came to our ophthalmology department with visual and campimetric worsening in both eyes (OU) since the last two months. He had a history of Behcet’s disease with severe ocular involvement (retinochoroidal) and bipolar aphtosis, previously treated with immunosuppressants and biologic therapy: adalimumab (ADA), infliximab, and azatriopine (AZA). At that time he was stable (no signs of activity) and following treatment with ADA 40 mg/month. </Pgraph><Pgraph>His best corrected visual acuity (BCVA) was 20/32 (Snellen chart) in his right eye (OD) and 20/63 in his left one (OS). Anterior segment was unremarkable for both eyes (OU). Fundus evaluation showed pigment clumps along the retinal veins with variable chorioretinal atrophy extending from the disc up to the equator in both eyes (clinically more evident in OS). Fundus autofluorescence (FAF) imaging revealed hypo-autofluorescent areas corresponding to the atrophic patches over the posterior pole (Figure 1 <ImgLink imgNo="1" imgType="figure"/> and Figure 2 <ImgLink imgNo="2" imgType="figure"/>). SS-OCT showed a preserved foveal profile and great macular atrophy in OU, but serious involvement of the retinal outer layers in the left eye (Figure 3 <ImgLink imgNo="3" imgType="figure"/> and Figure 4 <ImgLink imgNo="4" imgType="figure"/>). In Angio-OCT, severe involvement of the ellipsoid, choriocapillar, and avascular layers could be appreciated in OS.</Pgraph><Pgraph>Electroretinography (ERG) showed diffuse response peaks in OU, with marked peripheral involvement, in addition to an increase in latency and a decreased amplitude in scotopic and photopic stimulation resulting from a generalized and advanced bilateral photoreceptor dysfunction accompanied by macular anomalies. In visual field (VF) 24.2, there was a higher altitude defect in OR and a temporary defect in OS. A clinical diagnosis of pseudo-paravenous atrophy secondary to Behcet’s disease OU was done.</Pgraph></TextBlock> <TextBlock linked="yes" name="Discussion"> <MainHeadline>Discussion</MainHeadline><Pgraph>PPRCA is a rare entity that is currently not well described. The cause of this condition may be unknown or idiopathic, although a dysgenetic, degenerative, hereditary etiology or even an inflammatory cause hav been hypothesized <TextLink reference="5"></TextLink>. </Pgraph><Pgraph>PPRCA primarily involves the RPE, with secondary atrophy of the underlying choroidal vasculature <TextLink reference="6"></TextLink>, <TextLink reference="7"></TextLink>, <TextLink reference="8"></TextLink>. As the macula is often not affected, visual acuity keeps stable until advanced phases. Fundus appearance is quite characteristic, sometimes showing this paravenous atrophy and pigment accumulation. However, as other retinal cases can simulate PPRCA, we should support diagnosis with complementary tests. The use of a multimodal image can help us to differentiate this pathology from other similar pathologies as retinitis pigmentosa (RP) or acute zonal occult retinopathy (AZOR). </Pgraph><Pgraph>Fundus fluorescein angiography (FFA) shows diffuse window defects with hyperfluorescence (consistent with RPE degeneration) and blockage of fluorescence (in areas with pigment clumping along the retinal vessels) can be showed. In the more severe early arterial phase, FFA aspect turns to extensive areas of choriocapillaris atrophy with prominently visible choroidal vessels along the major retinal veins adjacent to the disc. In the arteriovenous phase, delimited hyperfluorescence can be observed at the edge of the atrophic area, with hypofluorescence corresponding with the areas of pigment migration. </Pgraph><Pgraph>Hypofluorescence in FAF shows the atrophy or disappearance of RPE because of a lipofuscin loss in RPE. Indeed, hypofluorescence detected by FAF corresponded to the areas of retinal thinning and atrophy detected using FA, IA, and OCT. In contrast, hyperfluorescence shows dysfunction of RPE that accumulates lipofuscin in RPE, suggesting the possibility of RPE atrophy in the future <TextLink reference="9"></TextLink>. In the case that we present, paravenous hypoautofluorescence could be appreciated. </Pgraph><Pgraph>SS-OCT scans normally reveal thinning of retinal layers with increased backscattering and disorganization of the RPE choriocapillaris complex. In many occasions, as we can see in our case, retinal and choroid slimming is such severe that scleral looks like very thick. Hyperreflective plaques with underlying shadowing corresponded to the pigment clumps observed clinically <TextLink reference="10"></TextLink>. OCT-A study is not correctly defined yet and we do not find explanatory signs in our patient. </Pgraph><Pgraph>Visual field shows peripheral scotomas corresponding to areas of chorioretinal atrophy. In advanced cases, the macula is also involved, so central visual field strategies as 10:2 VF should be used. </Pgraph><Pgraph>Electrodiagnostic data are variable and nonspecific, ranging between normal and mildly affected, even markedly subnormal or a totally extinguished electroretinogram (ERG) <TextLink reference="11"></TextLink>. This variation may signify that several conditions can present in this manner. In the case that we present, we can observe an alteration in photopic and scotopic response, more marked at periphery but with macular involvement too. Although some authors include PPCRA in the RP context based on clinical and electrophysiological state, PPRCA has a very slow progression compared to RP.</Pgraph><Pgraph>Diagnosis of pseudo-PPRCA can be achieved with a correct funduscopy suspect complemented with multimodal image study. </Pgraph><Pgraph>Differential diagnoses include chorioretinal degeneration and inflammatory diseases that cause chorioretinal atrophy, including RP (pericentral, sector and typical), helicoid peripapillary chorioretinal atrophy, serpiginous choroidopathy, angioid streaks, cone dystrophy or degeneration, Stickler syndrome, gyrate atrophy choroideremia, Wagner’s dominant vitreoretinal degeneration, sarcoidosis, syphilis, acute retinal necrosis, cytomegalovirus retinitis, tuberculous disseminated choroiditis, onchocerciasis, toxoplasmosis, frosted branch angiitis, and various disorders that are termed pseudoretinitis pigmentosa. We have to keep in mind that this entity could present as an isolated phenomena or be associated to other ocular disorder as Behcet’s disease (as we found in our case), tuberculosis or syphilis <TextLink reference="12"></TextLink>. </Pgraph></TextBlock> <TextBlock linked="yes" name="Conclusion"> <MainHeadline>Conclusion</MainHeadline><Pgraph>In summary, PPRCA is an uncommon disease, so exhaustive image studies must be performed for its correct definition and management. More cases would be needed to clarify the etiology of this entity and precise progression.</Pgraph></TextBlock> <TextBlock linked="yes" name="Notes"> <MainHeadline>Notes</MainHeadline><SubHeadline>Competing interests</SubHeadline><Pgraph>The authors declare that they have no competing interests.</Pgraph></TextBlock> <References linked="yes"> <Reference refNo="1"> <RefAuthor>Brown TH</RefAuthor> <RefTitle>Retino-choroiditis radiata</RefTitle> <RefYear>1937</RefYear> <RefJournal>Br J Ophthalmol</RefJournal> <RefPage>645-8</RefPage> <RefTotal>Brown TH. Retino-choroiditis radiata. Br J Ophthalmol. 1937 Dec;21(12):645-8. </RefTotal> </Reference> <Reference refNo="2"> <RefAuthor>Marsiglia M</RefAuthor> <RefAuthor>Duncker T</RefAuthor> <RefAuthor>Peiretti E</RefAuthor> <RefAuthor>Brodie SE</RefAuthor> <RefAuthor>Tsang SH</RefAuthor> <RefTitle>Unilateral retinitis pigmentosa: a proposal of genetic pathogenic mechanisms</RefTitle> <RefYear>2012</RefYear> <RefJournal>Eur J Ophthalmol</RefJournal> <RefPage>654-60</RefPage> <RefTotal>Marsiglia M, Duncker T, Peiretti E, Brodie SE, Tsang SH. Unilateral retinitis pigmentosa: a proposal of genetic pathogenic mechanisms. Eur J Ophthalmol. 2012 Jul-Aug;22(4):654-60. doi: 10.5301/ejo.5000086</RefTotal> <RefLink>http://dx.doi.org/10.5301/ejo.5000086</RefLink> </Reference> <Reference refNo="3"> <RefAuthor>Huang HB</RefAuthor> <RefAuthor>Zhang YX</RefAuthor> <RefTitle>Pigmented paravenous retinochoroidal atrophy (Review)</RefTitle> <RefYear>2014</RefYear> <RefJournal>Exp Ther Med</RefJournal> <RefPage>1439-45</RefPage> <RefTotal>Huang HB, Zhang YX. Pigmented paravenous retinochoroidal atrophy (Review). Exp Ther Med. 2014 Jun;7(6):1439-45. DOI: 10.3892/etm.2014.1648</RefTotal> <RefLink>http://dx.doi.org/10.3892/etm.2014.1648</RefLink> </Reference> <Reference refNo="4"> <RefAuthor>Chisholm IA</RefAuthor> <RefAuthor>Dudgeon J</RefAuthor> <RefTitle>Pigmented paravenous retino-choroidal atrophy: Helicoid retino-choriodal atrophy</RefTitle> <RefYear>1973</RefYear> <RefJournal>Br J Ophthalmol</RefJournal> <RefPage>584-7</RefPage> <RefTotal>Chisholm IA, Dudgeon J. Pigmented paravenous retino-choroidal atrophy: Helicoid retino-choriodal atrophy. Br J Ophthalmol. 1973 Aug;57(8):584-7. DOI: 10.1136/bjo.57.8.584</RefTotal> <RefLink>http://dx.doi.org/10.1136/bjo.57.8.584</RefLink> </Reference> <Reference refNo="5"> <RefAuthor>Pearlman JT</RefAuthor> <RefAuthor>Kamin DF</RefAuthor> <RefAuthor>Kopelow SM</RefAuthor> <RefAuthor>Saxton J</RefAuthor> <RefTitle>Pigmented paravenous retinochorodial atrophy</RefTitle> <RefYear>1975</RefYear> <RefJournal>Am J Ophthalmol</RefJournal> <RefPage>630-5</RefPage> <RefTotal>Pearlman JT, Kamin DF, Kopelow SM, Saxton J. Pigmented paravenous retinochorodial atrophy. Am J Ophthalmol. 1975 Oct;80(4):630-5. DOI: 10.1016/0002-9394(75)90393-1</RefTotal> <RefLink>http://dx.doi.org/10.1016/0002-9394(75)90393-1</RefLink> </Reference> <Reference refNo="6"> <RefAuthor>Yanagi Y</RefAuthor> <RefAuthor>Okajima O</RefAuthor> <RefAuthor>Mori M</RefAuthor> <RefTitle>Indocyanine green angiography in pigmented paravenous retinochoroidal atrophy</RefTitle> <RefYear>2003</RefYear> <RefJournal>Acta Ophthalmol Scand</RefJournal> <RefPage>60-7</RefPage> <RefTotal>Yanagi Y, Okajima O, Mori M. Indocyanine green angiography in pigmented paravenous retinochoroidal atrophy. Acta Ophthalmol Scand. 2003 Feb;81(1):60-7. DOI: 10.1034/j.1600-0420.2003.00003.x</RefTotal> <RefLink>http://dx.doi.org/10.1034/j.1600-0420.2003.00003.x</RefLink> </Reference> <Reference refNo="7"> <RefAuthor>von Rückmann A</RefAuthor> <RefAuthor>Fitzke FW</RefAuthor> <RefAuthor>Bird AC</RefAuthor> <RefTitle>In vivo fundus autofluorescence in macular dystrophies</RefTitle> <RefYear>1997</RefYear> <RefJournal>Arch Ophthalmol</RefJournal> <RefPage>609-15</RefPage> <RefTotal>von Rückmann A, Fitzke FW, Bird AC. In vivo fundus autofluorescence in macular dystrophies. Arch Ophthalmol. 1997 May;115(5):609-15. DOI: 10.1001/archopht.1997.01100150611006</RefTotal> <RefLink>http://dx.doi.org/10.1001/archopht.1997.01100150611006</RefLink> </Reference> <Reference refNo="8"> <RefAuthor>Ghosh B</RefAuthor> <RefAuthor>Goel N</RefAuthor> <RefAuthor>Batta S</RefAuthor> <RefAuthor>Raina UK</RefAuthor> <RefTitle>SD-OCT in pigmented paravenous retinochoroidal atrophy</RefTitle> <RefYear>2012</RefYear> <RefJournal>Ophthalmic Surg Lasers Imaging</RefJournal> <RefPage>e41-3</RefPage> <RefTotal>Ghosh B, Goel N, Batta S, Raina UK. SD-OCT in pigmented paravenous retinochoroidal atrophy. Ophthalmic Surg Lasers Imaging. 2012 May 10;43(3):e41-3. DOI: 10.3928/15428877-20120502-01</RefTotal> <RefLink>http://dx.doi.org/10.3928/15428877-20120502-01</RefLink> </Reference> <Reference refNo="9"> <RefAuthor>Batioglu F</RefAuthor> <RefAuthor>Atmaca LS</RefAuthor> <RefAuthor>Atilla H</RefAuthor> <RefAuthor>Arslanpençe A</RefAuthor> <RefTitle>Inflammatory pigmented paravenous retinochoroidal atrophy</RefTitle> <RefYear>2002</RefYear> <RefJournal>Eye (Lond)</RefJournal> <RefPage>81-4</RefPage> <RefTotal>Batioglu F, Atmaca LS, Atilla H, Arslanpençe A. Inflammatory pigmented paravenous retinochoroidal atrophy. Eye (Lond). 2002 Jan;16(1):81-4. DOI: 10.1038/sj.eye.6700021</RefTotal> <RefLink>http://dx.doi.org/10.1038/sj.eye.6700021</RefLink> </Reference> <Reference refNo="10"> <RefAuthor>Noble KG</RefAuthor> <RefTitle>Hereditary pigmented paravenous chorioretinal atrophy</RefTitle> <RefYear>1989</RefYear> <RefJournal>Am J Ophthalmol</RefJournal> <RefPage>365-9</RefPage> <RefTotal>Noble KG. Hereditary pigmented paravenous chorioretinal atrophy. Am J Ophthalmol. 1989 Oct 15;108(4):365-9. DOI: 10.1016/S0002-9394(14)73302-1</RefTotal> <RefLink>http://dx.doi.org/10.1016/S0002-9394(14)73302-1</RefLink> </Reference> <Reference refNo="11"> <RefAuthor>Choi JY</RefAuthor> <RefAuthor>Sandberg MA</RefAuthor> <RefAuthor>Berson EL</RefAuthor> <RefTitle>Natural course of ocular function in pigmented paravenous retinochoroidal atrophy</RefTitle> <RefYear>2006</RefYear> <RefJournal>Am J Ophthalmol</RefJournal> <RefPage>763-5</RefPage> <RefTotal>Choi JY, Sandberg MA, Berson EL. Natural course of ocular function in pigmented paravenous retinochoroidal atrophy. Am J Ophthalmol. 2006 Apr;141(4):763-5. DOI: 10.1016/j.ajo.2005.11.009</RefTotal> <RefLink>http://dx.doi.org/10.1016/j.ajo.2005.11.009</RefLink> </Reference> <Reference refNo="12"> <RefAuthor>Fernandez-Sanz G</RefAuthor> <RefAuthor>Carreño E</RefAuthor> <RefAuthor>Mall S</RefAuthor> <RefAuthor>Neveu MM</RefAuthor> <RefAuthor>Holder GE</RefAuthor> <RefAuthor>Thomas D</RefAuthor> <RefTitle>Unilateral Pigmented Paravenous Retinochoroidal Atrophy Associated With Presumed Ocular Tuberculosis</RefTitle> <RefYear>2017</RefYear> <RefJournal>Ophthalmic Surg Lasers Imaging Retina</RefJournal> <RefPage>345-349</RefPage> <RefTotal>Fernandez-Sanz G, Carreño E, Mall S, Neveu MM, Holder GE, Thomas D. Unilateral Pigmented Paravenous Retinochoroidal Atrophy Associated With Presumed Ocular Tuberculosis. Ophthalmic Surg Lasers Imaging Retina. 2017 Apr 1;48(4):345-349. DOI: 10.3928/23258160-20170329-10</RefTotal> <RefLink>http://dx.doi.org/10.3928/23258160-20170329-10</RefLink> </Reference> </References> <Media> <Tables> <NoOfTables>0</NoOfTables> </Tables> <Figures> <Figure format="png" height="492" width="624"> <MediaNo>1</MediaNo> <MediaID>1</MediaID> <Caption><Pgraph><Mark1>Figure 1: Autofluorescence image of the right eye showing hypoautofluorescence at the paravenous zone</Mark1></Pgraph></Caption> </Figure> <Figure format="png" height="492" width="624"> <MediaNo>2</MediaNo> <MediaID>2</MediaID> <Caption><Pgraph><Mark1>Figure 2: Autofluorescence image of the left eye demostrating hypoautofluorescence at the paravenous zone</Mark1></Pgraph></Caption> </Figure> <Figure format="png" height="536" width="634"> <MediaNo>3</MediaNo> <MediaID>3</MediaID> <Caption><Pgraph><Mark1>Figure 3: SS-OCT image of the right eye reveals external retina altered with an increase of choroidal signal due to retinal pigment epithelium atrophy.</Mark1></Pgraph></Caption> </Figure> <Figure format="png" height="536" width="634"> <MediaNo>4</MediaNo> <MediaID>4</MediaID> <Caption><Pgraph><Mark1>Figure 4: SS-OCT age of the left eye exhibits external retina damage with an increase in choroidal signal due to retinal pigment epithelium atrophy</Mark1></Pgraph></Caption> </Figure> <NoOfPictures>4</NoOfPictures> </Figures> <InlineFigures> <NoOfPictures>0</NoOfPictures> </InlineFigures> <Attachments> <NoOfAttachments>0</NoOfAttachments> </Attachments> </Media> </OrigData> </GmsArticle>